Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04367506
Other study ID # 1R34MH120142
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2021
Est. completion date June 2024

Study information

Verified date September 2023
Source University of Maryland, Baltimore
Contact Melanie Bennett, Ph.D.
Phone 410-706-2490
Email mbennett@som.umaryland.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to adapt a digital intervention both to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting through a collaboration between experts in SMI and the Truth Initiative, a pre-eminent tobacco control organization. The investigators believe this will bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.


Description:

Persons with serious mental illness (SMI) die on average 10-15 years earlier than those in the general population. Smoking is the strongest risk factor for their elevated mortality. Helping SMI smokers to quit is an urgent and unmet need. The hospital is an optimal setting to provide smoking cessation services. Hospital admissions for SMI are common with more than 1.2 million inpatient stays for schizophrenia and mood disorders per year in the US. Hospitalized patients experience required abstinence, are available for counseling, and can try cessation medications in a supportive setting. The challenge is how to engage SMI patients in cessation services post-discharge. An easy-to-access digital intervention is a scalable and sustainable way to bridge the inpatient-to-outpatient gap and to promote sustained abstinence. Digital interventions can deliver all elements of cessation treatment and yield quit rates comparable to face to face and telephonic interventions. SMI patients use and benefit from technology-based interventions but currently there is no digital smoking cessation program addressing their needs. This R34 application will adapt a proven digital intervention, BecomeAnEX (EX), developed and run by Truth Initiative for over 10 years. Its core components are real-time one on one coaching via live chat, nicotine replacement therapy decision support and delivery, personalized quit plans, a large online social network for peer support, a robust and fully integrated text message program, and tailored email messaging. Adaptation will ensure that EX addresses the specific challenges of SMI smokers and is in line with principles of mental health recovery. In Aim 1 the investigators will develop and obtain preliminary feedback about EX-SMI, a version of EX adapted for SMI patients. A priori target mechanisms are motivation, abstinence self-efficacy, and cravings. In Aim 2 the investigators will conduct a one-arm pilot trial and obtain feedback from 20 SMI smokers recruited during psychiatric hospitalization and followed up at 2-weeks and 1-month post-discharge. Feasibility and acceptability will be assessed via participant feedback regarding their intervention experience, changes in motivation, self-efficacy and cravings, and automated tracking data on EX-SMI use post-discharge. In Aim 3, 90 SMI smokers recruited during psychiatric hospitalization will be randomized to usual care or to a revised version of EX-SMI and followed for 3 months after the hospital stay. The investigators will compare the feasibility/acceptability of EX-SMI, measure intervention impact on target mechanisms, and obtain initial estimates of efficacy on 7-day point prevalence abstinence. This pilot work directly addresses priorities of this RFA in refining and optimizing an efficacious intervention for a new target population. Ultimately, this program of research could have a powerful public health impact by increasing smoking cessation among persons with SMI.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or greater - Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression) - Current smoker [prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime] - Interested in remaining quit after hospital discharge or quitting within the following 30 days - Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge. - Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing). - Reading competence as demonstrated by a score of >= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention. Exclusion Criteria: - Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness. - Homeless prior to admission or anticipated to be homeless at discharge. - Discharge to a residential setting where smoking is prohibited. - Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
BecomeAnEX
This research study is focused on a smoking cessation program called BecomeAnEx. We are studying how to adapt BecomeAnEx for people with a mental health disorder who want to reduce or quit their tobacco smoking. BecomeAnEx includes a website that provides education about smoking and quitting. It also has a text messaging program that delivers personalized information. Persons in the program have access to real-time digital coaching with a remote coach who has experience helping people quit smoking. In addition, the program has an on-line community of current and former smokers that can provide support and encouragement.
Usual Care
Usual care represents what hospitalized psychiatric patients normally receive in terms of smoking cessation: brief individual counseling, NRT during the hospital stay and a prescription for NRT at discharge (consistent with standard hospital procedures), and referral to the MD quitline.

Locations

Country Name City State
United States Melanie Bennett Baltimore Maryland
United States University of Maryland School of Medicine Baltimore Maryland

Sponsors (3)

Lead Sponsor Collaborator
University of Maryland, Baltimore Sheppard Pratt Health System, Truth Initiative

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of recruitment Rate of recruitment 3 months
Primary Feasibility of registration Time to register with the web based intervention 3 months
Primary Acceptability Satisfaction with the web based intervention using the Services Satisfaction Questionnaire 3 months
Primary Website utilization Time on website 3 months
Primary Smoking abstinence Self-report 7-day point prevalence abstinence 3 months
Primary Craving Tobacco Cravings Questionnaire 3 months
Primary Self-efficacy Smoking Situations Confidence Questionnaire 3 months
Primary Motivation to remain abstinent Abstinence-Related Motivational Engagement Scale 3 months
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Not yet recruiting NCT04501016 - A Stepped Care Approach to Treating Tobacco Use in Rural Veterans Phase 2/Phase 3
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Completed NCT01651611 - Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents N/A
Completed NCT01099384 - Tobacco Cessation Treatment for Alaska Native Youth Phase 1
Completed NCT01164306 - The Impact of a Tobacco Control Intervention in African-American Families N/A
Recruiting NCT04865276 - Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHealth Approach N/A
Recruiting NCT02103868 - Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers N/A
Completed NCT00836199 - NicVAX/Placebo as an Aid for Smoking Cessation Phase 3
Recruiting NCT05552534 - Impact of an Intervention of Screening, Treatment Initiation and Referral to PROmote Smoking CEssation in Emergency Department Patients N/A
Completed NCT01482923 - Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
Completed NCT05764343 - The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases N/A
Completed NCT03377738 - Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care N/A
Completed NCT01312480 - Adolescent Smoking Cessation in Pediatric Primary Care N/A
Completed NCT03096145 - Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers N/A
Completed NCT05095779 - Incentives for Smoking Cessation in Persistent Poverty Counties N/A
Completed NCT03062709 - A Study of Tobacco Smoke and Children With Respiratory Illnesses N/A
Completed NCT00750503 - Workplace Tobacco Cessation And Oral Cancer Screening Study Phase 3
Withdrawn NCT04340102 - Development of a Scalable Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness N/A
Completed NCT01331226 - Support Person Intervention to Promote a Smoking Helpline N/A